Answers are grounded in this paper and cite their sources.
Multi-omics Mendelian randomization identifies BMP6 and urate as key players in intervertebral disc degeneration, suggesting new treatment paths.
We prioritized BMP6 as a candidate therapeutic target for IVDD and identified circulating urate as a potential mediator based on a suggestive mediation signal. These findings offer new mechanistic insights into the potential relationship between BMP6, urate metabolism, and IVDD. This gene and its associated metabolite represent promising targets for IVDD intervention and may inform subsequent translational research and preclinical validation.
No takes yet. Share an insight, caveat, or question.
Kan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: